Aptus Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$453K	Sell	7,222 -70,813	-91%	-$5.66M	﹤0.01%	741
2025 Q4	$7.44M	Buy	78,035 +2,173	+3%	+$213K	0.06%	263
2025 Q3	$7.41M	Buy	75,862 +63,382	+508%	+$6.56M	0.07%	255
2025 Q2	$1.34M	Buy	12,480 +1,098	+10%	+$111K	0.01%	479
2025 Q1	$1.15M	Sell	11,382 -310	-3%	-$31.2K	0.01%	485
2024 Q4	$1.04M	Buy	11,692 +1,723	+17%	+$152K	0.01%	495
2024 Q3	$835K	Buy	9,969 +520	+6%	+$41K	0.01%	444
2024 Q2	$728K	Buy	9,449 +1,639	+21%	+$120K	0.01%	440
2024 Q1	$535K	Buy	7,810 +1,149	+17%	+$73.9K	0.01%	499
2023 Q4	$385K	Buy	6,661 +142	+2%	+$7.58K	0.01%	426
2023 Q3	$344K	Buy	+6,519	New	+$342K	0.01%	447
2022 Q4	–	Sell	-64,563	Closed	-$2.5M	–	805
2022 Q3	$2.5M	Sell	64,563 -23,683	-27%	-$950K	0.08%	184
2022 Q2	$3.29M	Sell	88,246 -490	-0.6%	-$19.9K	0.11%	132
2022 Q1	$3.93M	Buy	+88,736	New	+$3.85M	0.12%	118
2019 Q2	–	Sell	-68,767	Closed	-$2.64M	–	337
2019 Q1	$2.64M	Buy	+68,767	New	+$2.63M	0.46%	41